chemo effectiveness

Curtin University research to develop an early diagnosis tool predicting how cancer patients will respond to chemotherapy has received a funding boost of almost half a million dollars through the Innovation Seed Fund 2023-24. Led by Dr Yu Yu from Curtin Medical School and the Curtin Health Innovation Research Institute, the project seeks to create a diagnostic test to identify patients who will benefit from platinum-based chemotherapy, which is commonly used in combatting advanced cancers, but often has poor outcomes. Dr Yu said ineffective therapy affects up to 1,500 people in WA yearly and more than two million globally. “Unfortunately,

Funding boost for Curtin tool to predict chemo effectiveness as seen on The Hippocratic Post.